IDEXX Laboratories (NASDAQ:IDXX) shareholders approved all five management-backed proposals at the company’s 2026 annual meeting, including amendments to declassify the board and grant certain shareholders the right to call a special meeting, while rejecting a competing shareholder proposal seeking a lower ownership threshold for special meetings.
The virtual meeting also marked a leadership transition previously announced by the company. Larry Kingsley, IDEXX’s independent non-executive board chair, said Jay Mazelsky would step down as president and chief executive officer immediately following the annual meeting and become executive chair of the board. Mike Erickson, executive vice president and CEO-elect, will become president and CEO and join the board.
“We thank Jay for his outstanding leadership and dedicated service and look forward to continuing to work with him as executive chair, and we look forward to working with Mike as he leads IDEXX into its next chapter of growth and innovation,” Kingsley said.
Shareholders Approve Board Declassification
Sharon Underberg, IDEXX’s general counsel and corporate secretary, said a quorum was present and outlined six proposals before shareholders. Preliminary results showed shareholders elected Daniel M. Junius, Lawrence D. Kingsley and Sophie Vandebroek as class two directors, with each receiving a majority of the shares voted.
Shareholders also ratified PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for the current fiscal year and approved a non-binding advisory resolution on executive compensation.
Two governance-related management proposals also passed. Shareholders approved an amendment to IDEXX’s certificate of incorporation to declassify the board, a measure that required support from at least a majority of outstanding shares entitled to vote. They also approved an amendment providing shareholders owning 25% of IDEXX’s capital stock continuously for at least one year the right to have the company call a special meeting.
Underberg said final vote tallies, including ballots cast during the meeting, will be disclosed in a Form 8-K filing with the Securities and Exchange Commission within four business days.
Competing Special Meeting Proposal Fails
A shareholder proposal submitted by John Chevedden asked the company to give shareholders owning 10% of IDEXX shares the ability to call a special shareholder meeting. The board unanimously recommended voting against that proposal while supporting its own proposal establishing a 25% ownership threshold with a one-year holding requirement.
Chevedden, presenting the proposal during the meeting, argued that shareholders should have “a genuine ability to call for a special shareholder meeting” and criticized the company’s management proposal as too restrictive. He said the 25% threshold, the holding-period requirement and the length of the legal provisions would make the right difficult to use.
“Proposal five is like an insurance policy for IDEXX that has three separate ways for IDEXX to defeat any attempt by shareholders to call for a special shareholder meeting,” Chevedden said, urging shareholders to vote for the 10% threshold proposal.
Underberg said the shareholder proposal did not receive approval from a majority of shares voted and therefore failed.
Board Member Recognized for Service
During the meeting, Kingsley recognized retiring board member M. Anne Szostak, citing her 14 years of service to IDEXX. He said Szostak made “meaningful contributions to the board and to IDEXX’s growth and success,” particularly through her leadership, governance and human capital experience.
Kingsley said Szostak played an important role in the board’s oversight of “critically important matters,” including CEO and executive succession planning.
“On behalf of the board and senior management, I thank Anne for her extraordinary service, leadership, and contributions to IDEXX over the years,” Kingsley said.
No Shareholder Questions Submitted
After the formal business portion of the meeting was adjourned, the company opened a question-and-answer session. Kingsley said no questions had been submitted through the online pre-meeting forum and no questions were submitted online during the meeting. The operator also reported that no shareholders had questions by phone.
Underberg said the company would post answers to all submitted questions on its investor relations website as soon as practicable after the meeting. Kingsley closed the meeting by thanking shareholders for their participation and ongoing support of IDEXX.
About IDEXX Laboratories (NASDAQ:IDXX)
IDEXX Laboratories, Inc (NASDAQ: IDXX) is a global developer, manufacturer and provider of diagnostic products and services primarily for the animal health, water testing and food safety markets. Headquartered in Westbrook, Maine, the company supplies in-clinic diagnostic instruments, consumables, reference laboratory testing and practice-management tools that support veterinarians, livestock and dairy producers, and utilities and food producers worldwide.
IDEXX’s product portfolio includes point-of-care tests and immunoassays designed for rapid diagnosis in veterinary clinics, in-clinic chemistry and hematology analyzers, automated urinalysis systems, and digital diagnostic solutions.
